» Articles » PMID: 34377249

Effect of MiRNA-136-targeted Regulation of FGFR1 on Proliferation and Apoptosis of Triple-negative Breast Cancer Cells

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2021 Aug 11
PMID 34377249
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study was designed to investigate the effect of micro RNA-targeted regulation of FGFR1 on the proliferation and apoptosis of triple-negative breast cancer (TNBC) cells.

Methods: TNBC (MAD-MB-231), three types of breast cancer (MCF10A, MCF7, ZR751) cell lines, and normal breast tissue cell lines were extracted. Real-time PCR was used to detect the expression of miRNA-136 in different types of breast cells. The MAD-MB-231 cell lines were transfected with miRNA-136 mimic by lipofection. The effects of miRNA-136 on FGFR1 expression and apoptosis rate of MAD-MB-231 cell lines were determined using western blotting.

Results: miRNA-136 expression in TNBC cells was lower than that of controls, and was negatively correlated with TNM staging. miRNA-136 expression in MCF10A, MCF7, ZR751, and MAD-MB-231 cell lines was gradually decreased, and MCF10A expression in the other three cell lines was significantly higher than that of MAD-MB-231 cell line (P<0.05). Transfection with miRNA-136 significantly reduced the proliferation rate of MAD-MB-231, and a higher concentration and longer duration exhibited a more pronounced inhibitory effect on proliferation (P<0.05). Transfection with miRNA-136 significantly reduced FGFR1 expression in the MAD-MB-231 cell lines, without significantly affecting apoptosis.

Conclusion: miRNA-136 shows a very low expression level in TNBC cells. Transfection with miRNA-136 can significantly inhibit the proliferation of TNBC cells by external transfection, and has little effect on cell apoptosis. This may be related to miRNA-mediated changes in FGFR1 protein expression.

Citing Articles

FGFR families: biological functions and therapeutic interventions in tumors.

Liu Q, Huang J, Yan W, Liu Z, Liu S, Fang W MedComm (2020). 2023; 4(5):e367.

PMID: 37750089 PMC: 10518040. DOI: 10.1002/mco2.367.

References
1.
Charmet R, Duffy S, Keshavarzi S, Gyorgy B, Marre M, Rossing P . Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes. Cardiovasc Diabetol. 2018; 17(1):61. PMC: 5916834. DOI: 10.1186/s12933-018-0705-0. View

2.
Kwong J, Schwartz K, Campitelli M, Chung H, Crowcroft N, Karnauchow T . Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med. 2018; 378(4):345-353. DOI: 10.1056/NEJMoa1702090. View

3.
Bourgeois-Daigneault M, Roy D, Aitken A, El Sayes N, Martin N, Varette O . Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy. Sci Transl Med. 2018; 10(422). DOI: 10.1126/scitranslmed.aao1641. View

4.
Wang J, Gao Y, Duan L, Wei S, Liu J, Tian L . Metformin ameliorates skeletal muscle insulin resistance by inhibiting miR-21 expression in a high-fat dietary rat model. Oncotarget. 2017; 8(58):98029-98039. PMC: 5716711. DOI: 10.18632/oncotarget.20442. View

5.
Wu Z, He Y, Li D, Fang X, Shang T, Zhang H . Long noncoding RNA MEG3 suppressed endothelial cell proliferation and migration through regulating miR-21. Am J Transl Res. 2017; 9(7):3326-3335. PMC: 5553882. View